Article
RNAi screen identifies MAPK14 as a druggable suppressor of human hematopoietic stem cell expansion
4 May 2012
Abstract excerpt
We report on a forward RNAi screen in primary human hematopoietic stem and progenitor cells, using pooled lentiviral shRNA libraries deconvoluted by next generation sequencing. We identify MAPK14/p38α as a modulator of ex vivo stem cell proliferation and show that pharmacologic inhibition of p38 dramatically enhances the stem cell activity of cultured umbilical cord blood derived hematopoietic cells. p38...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
